Kazera Global (LON: KZG) has agreed a definitive settlement of $10.5m with Hebei Xinjian Construction in relation to the arbitration award concerning African Tantalum. This is a $7m loan repayment and $3.5m share sale component. There will be an initial payment of $500,000 in Namibia. The rest will be paid over a period up to the end of 2029 and Hebei will then own 100% of African Tantalum. If $9m is paid by the end of 2026 then that would be the total payment. The share price jumped 23.7% to 1.175p.
Europa Oil & Gas (LON: EOG) says the longstop agreement for the farm-out of a 40% stake in the EG-08 production sharing contract in offshore Equatorial Guinea has been extended to 31 July. Approvals are expected in the coming weeks. Europa will have a 42.9% interest in the operator which will continue to own 40%. The Barracuda-1 well in early 2027. Chief executive William Holland bought 642,101 shares at 1.44p each. The share price gained 18.5% to 1.6p.
Proteome Sciences (LON: PRM) has secured a further significant clinical contract for its engagement/chemoproteomics platform. The clinical trial will start in 2026. The share price improved 11.9% to 1.69p.
Tiger Alpha (LON: TIR) returned from suspension after it published an admission document for the reverse takeover of Potentially and a fundraising of £4.75m at 5p/share. It has also launched a retail offer to raise up to £250,000 at 5p/share. There will be a ten-for-one share consolidation. Potentially is developing a platform that helps people and businesses to protect and monetise what they create with AI. The company will change its name to Potentially AI. The share price increased 10.5% to 0.525p – 5.25p post consolidation.
Property services provider Fletcher King (LON: FLK) shares continue to rise and are up 10% to 55p, having been 60p earlier, after it declared a special dividend of 20p/share, which will cost £2.05m. The ex-dividend date is 2 July. Cash was £3.48m at the end of October 2025. Founder David Fletcher is leaving the board along with two other non-executives. That still leaves five directors.
FALLERS
Energy as a service provider eEnergy Group (LON: EAAS) expects interim revenues to be £22m and full year revenues to be £32m, compared with £38m previously. That means that EBITDA would be £1,7m rather than £4.5m. These adjustments come after the appointment of John Gahan as interim chief executive. He is generating annualised savings of £2m and there will be a restructuring charge of £500,000. eEnergy has a record of forecast downgrades over the years and it is no surprise that the share price has slumped 37.3% to 3.2p. This is the lowest it has been for three years.
Transense Technologies (LON: TRT) has been held back by foreign exchange and delays in the progress of development contracts. Revenues of £4.6m are below the forecast of £5.2m. Breakeven is likely. There should still be net cash at the end of June 2026. iTrack royalty revenues were as expected, but lower in terms of pounds. Customers of SAWsense have been slow to make decisions on development projects. There was also weaker demand for Translogik tyre measurement products. The 2026-27 forecast has also been cut to around breakeven. The share price declined 15.9% to 47.5p – a six year low.
Liquid biopsy technology developer CelLBxHealth (LON: CLBX) reported an underlying loss of £20.2m on revenues of £1.4m in 2025. Cost savings should cut the annual operating cash costs to £6.7m. That could help to cut this year’s loss to £6.2m. management needs to build up revenues and there is increasing interest in the company’s services. The share price fell 11.4% to 1.55p.
Forgent (LON: FORG) has started its maiden drilling programme at the Peak Hills gold copper project in Western Australia and the results should be reported in August. Forgent has a 51% interest, and this can be raised to 99%. The share price slipped 5.88% to 0.016p.